Sponsored Links
| TMX-67 (Febuxostat) Approved In Japan - Teijin-Developed Novel Drug For Chronic Management Of Hyperuricemia |
 |
 |
 |
| Medical News - Gout | |
|
Teijin Pharma Limited, the core company of the Teijin Group's medical and pharmaceutical business, announced today that Japan's Ministry of Health, Labour and Welfare approved TMX-67 (febuxostat), Teijin Pharma's novel drug for treating hyperuricemia, on January 21... Read more: Gout News From Medical News Today
|